APA (7th ed.) Citation

OH, A., RB, I., T, U., IT, U., E, A., HS, S., . . . S, Y. (2026). Baseline serum folic acid as a prognostic biomarker in metastatic renal cell carcinoma treated with targeted therapy. Discover oncology, 17(1), . https://doi.org/10.1007/s12672-026-04798-4

Chicago Style (17th ed.) Citation

OH, Aktepe, Izgor RB, Ulasli T, Unek IT, Atag E, Semiz HS, Karaoglu A, Erman M, and Yalcin S. "Baseline Serum Folic Acid as a Prognostic Biomarker in Metastatic Renal Cell Carcinoma Treated with Targeted Therapy." Discover Oncology 17, no. 1 (2026). https://doi.org/10.1007/s12672-026-04798-4.

MLA (9th ed.) Citation

OH, Aktepe, et al. "Baseline Serum Folic Acid as a Prognostic Biomarker in Metastatic Renal Cell Carcinoma Treated with Targeted Therapy." Discover Oncology, vol. 17, no. 1, 2026, https://doi.org/10.1007/s12672-026-04798-4.